SecBot SecBot
SECBOTREPLAY Home › Report › CTNM

CTNM · Two C-suite insiders at Contineum Therapeutics (CEO and CSO) sold a…

Contineum Therapeutics, Inc. · CLUSTER filed Jul 8, 2026 at 18:49 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 8, 2026 at 18:49 ET

Two C-suite insiders at Contineum Therapeutics (CEO and CSO) sold a combined $132K in open-market sales over a 7-day window. The total value represents just 0.024% of the company's $544M market cap, making this a trivial, routine cluster with no material signal.

  • CEO Carmine Stengone sold 2,500 shares at $16.00 for $40K on 2026-07-08
  • CSO Daniel Lorrain sold 5,900 shares at $15.67 for $92K on 2026-07-01
  • Total insider sales of $132K represent ~0.024% of CTNM's $544M market cap
  • CEO also exercised non-cash derivative transactions on the same day (no economic impact)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access